AZN - AstraZeneca to invest $300M in new US cell therapy plant
2024-02-06 11:21:13 ET
More on AstraZeneca
- AstraZeneca's Q4 Earnings: Recognizing The Underrated Gem's Growth
- Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win
- AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition
- Earnings week ahead: Alibaba, PepsiCo, Disney, Palantir, McDonalds, Ford and more
- AstraZeneca/ Daiichi win FDA priority review for Enhertu label expansion